Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Background: Functional mitral regurgitation (FMR) is a common finding in patients with heart failure (HF), but its effect on outcome is still uncertain, mainly because in previous studies sample sizes were relatively small and semiquantitative methods for FMR grading were used. Objective: To evaluate the prognostic value of FMR in patients with HF. Methods and results: Patients with HF due to ischaemic and non-ischaemic dilated cardiomyopathy (DCM) were retrospectively recruited. The clinical end point was a composite of all-cause mortality and hospitalisation for worsening HF. FMR was quantitatively determined by measuring vena contracta (VC) or effective regurgitant orifice (ERO) or regurgitant volume (RV). Severe FMR was defined as ERO >0.2 cm 2 or RV >30 ml or VC >0.4 cm. Restrictive mitral filling pattern (RMP) was defined as E-wave deceleration time <140 ms. The study population comprised 1256 patients (mean age 67±11; 78% male) with HF due to DCM: 27% had no FMR, 49% mild to moderate FMR and 24% severe FMR. There was a powerful association between severe FMR and prognosis (HR=2.0, 95% CI 1.5 to 2.6; p<0.0001) after adjustment of left ventricular ejection fraction and RMP. The independent association of severe FMR with prognosis was confirmed in patients with ischaemic DCM (HR=2.0, 95% CI 1.4 to 2.7; p<0.0001) and non-ischaemic DCM (HR=1.9, 95% CI 1.3 to 2.9; p=0.002). Conclusion: In a large patient population it was shown that a quantitatively defined FMR was strongly associated with the outcome of patients with HF, independently of LV function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zoghbi, W. A., Enriquez-Sarano, M., Foster, E., Grayburn, P. A., Kraft, C. D., Levine, R. A., Nihoyannopoulos, P., Otto, C. M., Quinones, M. A., Rakowski, H., et al. (2003) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(03)00335-3 · Cited by 4,044
Self-citationLancellotti, P., Moura, L., Pierard, L. A., Agricola, E., Popescu, B. A., Tribouilloy, C., Hagendorff, A., Monin, J. L., Badano, L., Zamorano, J. L., et al. (2010) · European Journal of Echocardiography · doi:10.1093/ejechocard/jeq031 · Cited by 1,545
Self-citationGrigioni, F., Enriquez-Sarano, M., Zehr, K. J., Bailey, K. R., & Tajik, A. J. (2001) · Circulation · doi:10.1161/01.cir.103.13.1759 · Cited by 1,429
Self-citationQuantitative Determinants of the Outcome of Asymptomatic Mitral Regurgitation
Enriquez-Sarano, M., Avierinos, J.-F., Messika-Zeitoun, D., Detaint, D., Capps, M., Nkomo, V., Scott, C., Schaff, H. V., & Tajik, A. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041451 · Cited by 1,161
Self-citationWu, A. H., Aaronson, K. D., Bolling, S. F., Pagani, F. D., Welch, K., & Koelling, T. M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.09.073 · Cited by 709
Clinical Outcome of Mitral Regurgitation Due to Flail Leaflet
Ling, L. H., Enriquez-Sarano, M., Seward, J. B., Tajik, A. J., Schaff, H. V., Bailey, K. R., & Frye, R. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611073351902 · Cited by 665
Self-citationBreithardt, O. A., Sinha, A. M., Schwammenthal, E., Bidaoui, N., Markus, K. U., Franke, A., & Stellbrink, C. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02937-6 · Cited by 517
Rihal, C. S., Nishimura, R. A., Hatle, L. K., Bailey, K. R., & Tajik, A. J. (1994) · Circulation · doi:10.1161/01.cir.90.6.2772 · Cited by 438
Giannuzzi, P., Imparato, A., Temporelli, P. L., Vito, F. D., Silva, P. L., Scapellato, F., & Giordano, A. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90667-x · Cited by 362
Self-citationLittle, W. C., Ohno, M., Kitzman, D. W., Thomas, J. D., & Cheng, C.-P. (1995) · Circulation · doi:10.1161/01.cir.92.7.1933 · Cited by 305
Cited by
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation
Zoghbi, W. A., Adams, D., Bonow, R. O., Enriquez-Sarano, M., Foster, E., Grayburn, P. A., Hahn, R. T., Han, Y., Hung, J., Lang, R. M., et al. (2017) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2017.01.007 · Cited by 3,556
Self-citation2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.011 · Cited by 3,339
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,905
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000029 · Cited by 2,566
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000503 · Cited by 2,497
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000932 · Cited by 2,449
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.018 · Cited by 1,982
Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation
Obadia, J.-F., Messika-Zeitoun, D., Leurent, G., Iung, B., Bonnet, G., Piriou, N., Lefèvre, T., Piot, C., Rouleau, F., Carrié, D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805374 · Cited by 1,806
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O'Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.537 · Cited by 1,642
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.035 · Cited by 1,075
2014 AHA/ACC guideline for the management of patients with valvular heart disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.05.014 · Cited by 989
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation
Goldstein, D., Moskowitz, A. J., Gelijns, A. C., Ailawadi, G., Parides, M. K., Perrault, L. P., Hung, J. W., Voisine, P., Dagenais, F., Gillinov, A. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512913 · Cited by 972
Global epidemiology of valvular heart disease
Coffey, S., Roberts-Thomson, R., Brown, A., Carapetis, J., Chen, M., Enriquez-Sarano, M., Zühlke, L., & Prendergast, B. D. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00570-z · Cited by 770
Self-citationProportionate and Disproportionate Functional Mitral Regurgitation
Grayburn, P. A., Sannino, A., & Packer, M. (2019) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2018.11.006 · Cited by 651
The Diagnosis and Evaluation of Dilated Cardiomyopathy
Japp, A. G., Gulati, A., Cook, S. A., Cowie, M. R., & Prasad, S. K. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.590 · Cited by 554
Secondary Mitral Regurgitation in Heart Failure
Asgar, A. W., Mack, M. J., & Stone, G. W. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.009 · Cited by 489
Epidemiology of Acquired Valvular Heart Disease
Iung, B., & Vahanian, A. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.03.022 · Cited by 388
Refining the prognostic impact of functional mitral regurgitation in chronic heart failure
Goliasch, G., Bartko, P. E., Pavo, N., Neuhold, S., Wurm, R., Mascherbauer, J., Lang, I. M., Strunk, G., & Hülsmann, M. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx402 · Cited by 361
Seferović, P. M., Polovina, M., Bauersachs, J., Arad, M., Ben Gal, T., Lund, L. H., Felix, S. B., Arbustini, E., Caforio, A. L. P., Farmakis, D., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1461 · Cited by 346
Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation: PRIME Study
Kang, D.-H., Park, S.-J., Shin, S.-H., Hong, G.-R., Lee, S., Kim, M.-S., Yun, S.-C., Song, J.-M., Park, S.-W., & Kim, J.-J. (2019) · Circulation · doi:10.1161/circulationaha.118.037077 · Cited by 340
The modern epidemiology of heart valve disease
Coffey, S., Cairns, B. J., & Iung, B. (2016) · Heart · doi:10.1136/heartjnl-2014-307020 · Cited by 321
2020 ACC/AHA guideline for the management of patients with valvular heart disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.04.002 · Cited by 279
Dilated Cardiomyopathy: From Genetics to Clinical Management
(2019) · doi:10.1007/978-3-030-13864-6 · Cited by 32
Metadata
- Authors
- Rossi, A., Dini, F. L., Faggiano, P., Agricola, E., Cicoira, M., Frattini, S., Simioniuc, A., Gullace, M., Ghio, S., Enriquez-Sarano, M., & Temporelli, P. L.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 2011-07-31
- Volume
- 97
- Issue
- 20
- Pages
- 1675-1680
- ISSN
- 1355-6037 (ISSN-L)
- 1468-201X
- OpenAlex
- W2151173136
- Cited by
- 572
- References
- 22
- FWCI
- 13.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.